Pharmalot By Ed Silverman Pharmalittle: Biogen Alzheimer’s drug revival sparks skepticism; docs chide blood-thinner recommendations
Pharmalot By Ed Silverman AmerisourceBergen will eliminate 15 percent of workers at a troubled compounding unit
Pharmalot By Ed Silverman Pharmalittle: Pfizer paid its CEO how much? Glaxo says Brexit will not be cheap
